Riskpilot← Back to searchSign inGet full accessØRENESEHALS KLINIKKEN AS
ASActiveOrg 916618875Lilleeng Helsepark Rosenvinges Vei 8, 1523 MossMedical specialists activities · NACE 8622Est. 20165 employees
Revenue 2024
NOK 13,4M
-3% vs 2023
EBITDA margin
20.4%
-43% vs 2023
Equity ratio
0.8%
Financial strength
Net profit 2024
NOK 1,3M
-61% vs 2023
| Revenue | NOK 13,4M | -3% |
| EBITDA | NOK 2,7M | -43% |
| Net profit | NOK 1,3M | -61% |
| Total assets | NOK 4,8M | -34% |
| Equity | NOK 38K | -97% |
| Employees | 5 | — |
Legal name
ØRENESEHALS KLINIKKEN AS
Org number
916618875
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
25. januar 2016
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Helsetjenester innenfor øre-nese-hals, samt konsulenttjenester og alt som står i naturlig forbindelse med dette, herunder direkte og indirekte investeringer i foretak som driver slik virksomhet.
Address
Lilleeng Helsepark Rosenvinges Vei 8, 1523 Moss
Phone
+4769202150
Email
finn@lilleenghelsepark.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 046 | 15 107 | 15 028 | 13 837 | 13 401 |
| Staff expenses | −6 202 | −5 667 | −5 603 | −6 951 | −7 210 |
| EBITDA | 3 808 | 5 138 | 6 174 | 4 754 | 2 728 |
| Depreciation & amort. | −705 | −622 | −204 | −320 | −585 |
| EBIT | 3 103 | 4 516 | 5 970 | 4 434 | 2 143 |
| Net financials | −21 | −27 | −213 | −159 | −137 |
| Profit before tax | 3 082 | 4 490 | 5 757 | 4 275 | 2 006 |
| Tax | 678 | 988 | 1 305 | 963 | 709 |
| Net profit | 2 404 | 3 502 | 4 452 | 3 312 | 1 297 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 999 | 6 475 | 7 974 | 7 231 | 4 786 |
| Equity | 534 | 536 | 1 638 | 1 351 | 38 |
| Long-term debt | 415 | 291 | 807 | 1 522 | 1 378 |
| Short-term debt | 4 049 | 5 647 | 5 528 | 4 359 | 3 370 |
| Total debt | 4 464 | 5 939 | 6 336 | 5 881 | 4 748 |
EBITDA margin
20.4%
This company
15.8%
Market median
+29% vs market
20202024
Equity ratio
0.8%
This company
38.2%
Market median
-98% vs market
20202024
Return on equity
3438.3%
This company
18.4%
Market median
+18586% vs market
20202024
Net profit margin
9.7%
This company
8.1%
Market median
+20% vs market
20202024
Asset turnover
2.80×
This company
1.12×
Market median
+150% vs market
20202024
Debt / equity
125.87×
This company
0.62×
Market median
-20202% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KM Chief Executive Officer | Chief Executive Officer | 2016 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ØRENESEHALS KLINIKKEN AS 
EJJI ASBoard members of ØRENESEHALS KLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristian Mydske Vegsgaard | Chief Executive Officer | 0 companies |